Nanoemulsion Market (Drug Class - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, and Vasodilators; Route of Administration - Topical, Oral, Parenteral, and Nasal; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Global Nanoemulsion Market: Snapshot
There are various ways in which established players are trying to increase their stronghold over the global market for Nanoemulsion. Expanding outreach in developing markets that offer enormous opportunities to grow is one of them. Besides, they also have a strong pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases.
There are many factors currently boosting the global Nanoemulsion market. Some of them are the technological progress in the pharmaceutical and biotechnology industry, rising instances of chronic diseases, increasing awareness about their treatments, growing demand for more target specific drug delivery systems, and supportive policies of governments. New product launches is also proving to be immensely beneficial for the market.
The other factors responsible for the growth in the market include higher allocations for healthcare infrastructure, rising economic stability, and increasing participation of major market players in in developing economies such as Latin America and the Middle East and Africa.
On account of the aforementioned growth drivers, a report by Transparency Market Research projects the global Nanoemulsion market to rise at a healthy 9.2% CAGR from 2017 and 2025 to become worth US$14.91 bn by 2025 from US$6.78 bn in 2016.
Immunosuppressant See Maximum Uptake
The global market for Nanoemulsion can be segmented based on different parameters. Depending upon the type of drugs, for example, it can be segmented into steroids, anesthetics, NSAIDs, antiretroviral, antimicrobials, vasodilators, immunosuppressant, etc. Of them, the segment of NSAIDs is slated to outpace all others vis-à-vis growth rate by registering a CAGR of 10.1% from 2017 to 2025. This is because of the rising use Nanoemulsion formulation in topical and other drug administration routes for more effective drug delivery allowing for rapid penetration. In terms of market share, however, the segment of immunosuppressant lead the way with 21.3% share in the global Nanoemulsion market in 2016.
Emphasis on Product Development Drives North America Market
From a geographical perspective, North America at present dominates the global Nanoemulsion market. By expanding at a CAGR of 9.3%, the region is expected to pull in a revenue of US$5.96 bn in 2025. The dominant position of the region is a result of a well-established pharmaceutical and biotechnology industry, thrust on research activities for product development, and increasing prevalence of chronic disorders. Europe trails North America vis-à-vis market share. The revenue in the region is predicted to grow to US$5.217 by 2025.
While Europe and North America are dominant in the Nanoemulsion market in terms of size, Asia Pacific will likely run the show when it comes to growth pace by clocking the maximum CAGR of 9.4% during period between 2017 and 2025. The changing demographics and the increasing incomes of people in the region, particularly in the densely populated countries of China and India, are serving to drive growth in the region.
Latin America is another region that is projected to emerge as a profitable on account of governments’ initiatives to promote pharmaceutical and healthcare industries and the increasing healthcare expenditure. The Middle East and Africa Nanoemulsion market, on the other hand, is expected to grow because of the increasing number of products and initiatives by governments to promote research and development.
Prominent participants operating in the global market for Nanoemulsion are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG.
Nanoemulsion Market is witnessing notable revenues due to Major Adoption by Personal Care Industry
There are different strategies by which set up players are attempting to build their fortress over the worldwide market for nanoemulsion. Extending effort in creating markets that offer huge chances to develop is one of them. Plus, they additionally have a solid pipeline of nanoemulsion based antibodies against flu, Bacillus anthracis, chlamydia contamination, a few explicitly communicated contaminations, and respiratory infections.
There are numerous elements as of now boosting the worldwide nanoemulsion market. Some of them are the innovative advancement in the drug and biotechnology industry, rising occurrences of constant sicknesses, expanding mindfulness about their therapies, developing interest for more objective explicit medication conveyance frameworks, and steady approaches of governments.
New item dispatches are likewise ending up being monstrously advantageous for the market.
Nanoemulsion can break up enormous measure of hydrophobics combined with capacity of shielding drugs from cycles, for example, hydrolysis and enzymatic debasement make them ideal transporter. The few benefits of nanoemulsion over ordinary emulsion including miniature bead size of nanoemulsion with higher proficiency as a superior transporter. The previously mentioned factors are driving development of the worldwide nanoemulsion market.
Various driving factors such as fast innovative advances in the field of drugs and biotechnology industry, expanding mindfulness about persistent sicknesses and accessibility of therapies are emphatically impacting development of the worldwide nanoemulsion market. Moreover, various government approaches preferring the objective explicit medications conveyance frameworks are boosting appropriation of target explicit medication conveyance frameworks which is fuelling development of the worldwide nanoemulsion market. Dispatch of mechanically progressed items to satisfy the need for effective medication conveyance frameworks is decidedly affecting on a development of the worldwide nanoemulsion market.
Nonetheless, fabricating cost of nanoemulsion is controlling development of the worldwide nanoemulsion market. By the by, different headways like the no impacts of flocculation and sedimentation, and non-harmful nature makes them reasonable to be utilized in excellence items and infant care items like creams and salves. The appropriation from individual consideration industry has set out rewarding open doors for central participants in the worldwide nanoemulsion market for development and high income age.
Nanoemulsion Market: Snapshot
Nanoemulsion is the procedure of suspension of minimicrons of globules of one fluid to different fluids that are immiscible to each other. Nanoemulsions are oil-in-water emulsions with mean size extending from 50 to 1000 nm. Normal size of a bead is in the vicinity of 100 and 500 nm. Nanoemulsions are produced using surfactants endorsed for human utilization and sustenance substances that are perceived as protected by the U.S. FDA. Nanoemulsion can be readied utilizing a few strategies, for example, smaller scale fluidization, high weight homogenization and sonication. Nanoemulsion is likewise called miniemulsion, ultrafine emulsion, and submicron emulsion. Nanoemulsion can break up vast amounts of hydrophobics, this alongside its high similarity and capacity to shield drugs from hydrolysis and enzymatic debasement make them perfect vehicles for transport.
Nanoemulsion Market: Trends and Opportunities
Serving to significantly fuel the worldwide market for nanoemulsion is the quick innovative advance in the pharmaceutical and biotechnology industry, rising cases of endless maladies, expanding mindfulness about their medications, developing interest for more target particular medication conveyance frameworks, and strong approaches of governments. Rise of mechanically progressed new items is likewise positively affecting the worldwide Nanoemulsion market.
Alternate variables in charge of the development the market incorporate expanding human services framework, expanding monetary strength, expanding cooperation of significant market players in creating economies, for example, Latin America and the Middle East and Africa. Expanding interest for more effective medication conveyance frameworks and expanding innovative work is required to drive the market amid the estimate time frame.
As the nanoemulsions don't experience flocculation or sedimentation they are perfect for use in infant mind wipes or make-up evacuation applications. This is another development driver in the market. As nanoemulsions are non-lethal and non-aggravation they are broadly utilized as a part of healthy skin beautifying agents. Nonetheless, the cost of nanoemulsions readiness can turn out to be a hindrance to the nanoemulsions market.
Nanoemulsion Market: Geographical Analysis
From a geographical point of view, North America currently commands the worldwide nanoemulsion market. By extending at a robust CAGR of 9.3%, the region is relied upon to pull in a revenue of US$ 5.96 bn in year 2025. The prevailing position of the area is a consequence of a settled pharmaceutical and biotechnology industry, based on research procedures for item improvement, and expanding predominance of incessant issue. Europe trails North America versus market share. While Europe and North America are predominant in the nanoemulsion market as far as size is concerned, Asia Pacific will probably run the show with regards to development pace by timing the greatest CAGR of 9.4% within the forecast period from 2017 to 2025. The changing socioeconomics and the expanding salaries of individuals in the region, especially in the thickly populated nations of India and China, are serving to drive development in the area.
Latin America is another locale that is anticipated to develop as a beneficial because of government’ to advance pharmaceutical and social insurance enterprises and the expanding human services consumption. The Middle East and Africa nanoemulsion market, then again, is required to develop due to the expanding number of items and activities by governments to advance innovative work.
Nanoemulsion Market: Companies Mention
Allergan plc, AstraZeneca Inc., Novartis AG, B. Braun Melsungen AG, Mitsubishi Tanabe Pharma Corporation, AbbVie Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., and Sanofi, are some of the major players in the globala nanoemulsion market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section-2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global Nanoemulsion Market: Market Snapshot
3.2 Global Nanoemulsion Market: Opportunity Map
Section-4 Market Overview
4.1 Global Nanoemulsion Market: Product Overview
4.2 Global Nanoemulsion Market: Key Industry Developments
Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Nanoemulsion Market Revenue Forecast
5.5 Porter’s Five Forces Analysis
5.6 PEST Analysis
5.7 Value Chain Analysis
5.8 Global Nanoemulsion Market Outlook
Section-6 Global Nanoemulsion Market Analysis, by Drug Class
6.1 Key Findings
6.3 Global Nanoemulsion Market Value Share Analysis, by Drug Class
6.4 Global Nanoemulsion Market Forecast, by Drug Class
6.5 Global Nanoemulsion Market Attractiveness Analysis, By Drug Class
Section-7 Global Nanoemulsion Market Analysis, by Route of Administration
7.1 Key Findings
7.3 Global Nanoemulsion Market Value Share Analysis, by Route of Administration
7.4 Market Value (US$ Mn) Forecast By Route of Administration
7.5 Global Nanoemulsion Market Attractiveness Analysis, By Route of Administration
Section-8 Global Nanoemulsion Market Analysis, by Distribution Channel
8.1 Key Findings
8.3 Global Nanoemulsion Market Value Share Analysis, by Distribution Channel
8.4 Market Value (US$ Mn) Forecast By Distribution Channel
8.4.1 Hospital Pharmacies
8.4.2 Retail Pharmacies
8.5 Global Nanoemulsion Market Attractiveness Analysis, By Distribution Channel
Section-9 Global Nanoemulsion Market Analysis, by Region
9.1 Geographical Scenario
9.3 Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025
9.4 Nanoemulsion Market Forecast, by Region
9.4.1 North America
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.1 Middle East & Africa
9.5. Nanoemulsion Market Attractiveness Analysis, By Region, 2017 and 2025
Section-10 North America Nanoemulsion Market Analysis and Forecast
10.1 Key Findings
10.2 Market Value (US$ Mn) Forecast, By Country
10.3 Market Value (US$ Mn) Forecast By Drug Class
10.4 Market Value (US$ Mn) Forecast By Route of Administration
10.5 Market Value (US$ Mn) Forecast By Distribution Channel
10.6 Market Attractiveness Analysis
10.6.1 By Country
10.6.2 By Drug Class
10.6.3 By Route of Administration
10.6.4 By Distribution Channel
Section-11 Europe Nanoemulsion Market Analysis and Forecast
11.1 Key Findings
11.2 Market Value (US$ Mn) Forecast, By Country
11.2.6 Rest of Europe
11.3 Market Value (US$ Mn) Forecast By Drug Class
11.4 Market Value (US$ Mn) Forecast By Route of Administration
11.5 Market Value (US$ Mn) Forecast By Distribution Channel
11.6 Market Attractiveness Analysis
11.4.1 By Country
11.4.2 By Drug Class
11.4.3 By Route of Administration
11.4.4 By Distribution Channel
Sectin-12 Asia Pacific Nanoemulsion Market Analysis and Forecast
12.1 Key Findings
12.2 Market Value (US$ Mn) Forecast, By Country
12.2.5 Rest of APAC
12.3 Market Value (US$ Mn) Forecast By Drug Class
12.4 Market Value (US$ Mn) Forecast By Route of Administration
12.5 Market Value (US$ Mn) Forecast By Distribution Channel
12.6 Market Attractiveness Analysis
12.4.1 By Country
12.4.2 By Drug Class
12.4.3 By Route of Administration
12.4.4 By Distribution Channel
Section-13 Latin America Nanoemulsion Market Analysis and Forecast
13.1 Key Findings
13.2 Market Value (US$ Mn) Forecast, By Country
13.2.3 Rest of LATAM
13.2.5 Rest of APAC
13.3 Market Value (US$ Mn) Forecast By Drug Class
13.4 Market Value (US$ Mn) Forecast By Route of Administration
13.5 Market Value (US$ Mn) Forecast By Distribution Channel
13.6 Market Attractiveness Analysis
13.4.1 By Country
13.4.2 By Drug Class
13.4.3 By Route of Administration
13.4.4 By Distribution Channel
Section-14 Latin America Nanoemulsion Market Analysis and Forecast
14.1 Key Findings
14.2 Market Value (US$ Mn) Forecast, By Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 Rest of MEA
14.3 Market Value (US$ Mn) Forecast By Drug Class
14.4 Market Value (US$ Mn) Forecast By Route of Administration
14.5 Market Value (US$ Mn) Forecast By Distribution Channel
14.6 Market Attractiveness Analysis
14.4.1 By Country
14.4.2 By Drug Class
14.4.3 By Route of Administration
14.4.4 By Distribution Channel
Section-15 Competition Landscape
15.1 Global Nanoemulsion Market Share Analysis, by Company (2016)
15.2 Competition Matrix
15.3 Company profiles
15.3.1 AbbVie Inc.
22.214.171.124 Company Details
126.96.36.199 Business Overview
188.8.131.52 Financial Overview
184.108.40.206 Strategic Overview
220.127.116.11 SWOT Analysis
15.3.2 Allergan plc.
18.104.22.168 Company Details
22.214.171.124 Business Overview
126.96.36.199 Financial Overview
188.8.131.52 Strategic Overview
184.108.40.206 SWOT Analysis
220.127.116.11 Company Details
18.104.22.168 Business Overview
22.214.171.124 Financial Overview
126.96.36.199 Strategic Overview
188.8.131.52 SWOT Analysis
15.3.4 Fresenius Kabi AG
184.108.40.206 Company Details
220.127.116.11 Business Overview
18.104.22.168 Financial Overview
22.214.171.124 Strategic Overview
126.96.36.199 SWOT Analysis
15.3.5 Kaken Pharmaceutical Co., Ltd.
188.8.131.52 Company Details
184.108.40.206 Business Overview
220.127.116.11 Financial Overview
18.104.22.168 Strategic Overview
22.214.171.124 SWOT Analysis
15.3.6 Mitsubishi Tanabe Pharma Corporation
126.96.36.199 Company Details
188.8.131.52 Business Overview
184.108.40.206 Financial Overview
220.127.116.11 Strategic Overview
18.104.22.168 SWOT Analysis
15.3.7 NanoBio Corporation
22.214.171.124 Company Details
126.96.36.199 Business Overview
188.8.131.52 Financial Overview
184.108.40.206 Strategic Overview
220.127.116.11 SWOT Analysis
15.3.8 Novartis AG
18.104.22.168 Company Details
22.214.171.124 Business Overview
126.96.36.199 Financial Overview
188.8.131.52 Strategic Overview
184.108.40.206 SWOT Analysis
15.3.9 GlaxoSmithKline plc.
220.127.116.11 Company Details
18.104.22.168 Business Overview
22.214.171.124 Financial Overview
126.96.36.199 Strategic Overview
188.8.131.52 SWOT Analysis
184.108.40.206 Company Details
220.127.116.11 Business Overview
18.104.22.168 Financial Overview
22.214.171.124 Strategic Overview
126.96.36.199 SWOT Analysis
15.3.11 B. Braun Melsungen AG
188.8.131.52 Company Details
184.108.40.206 Business Overview
220.127.116.11 Financial Overview
18.104.22.168 Strategic Overview
22.214.171.124 SWOT Analysis
List of Tables
Table 01: List of Commercially Available Nanoemulsion
Table 02: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 03: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 04: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 05: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 07: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 08: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 09: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Europe Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 11: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 12: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 13: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 14: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 16: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 17: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Latin America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 19: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 20: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 21: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 22: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 25: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025